(1 - 10 von 11
)
MEDA.S - Medartis Holding AG | Stock Price & Latest News | Reuters
www.reuters.com
Deputy Chief Executive Officer, Chief Financial Officer, Member of the Management Board. Dominik Ellenrieder. Vice Chairman of the Board of Directors.
Cytos Biotechnology and Kuros Biosurgery to combine to ...
pipelinereview.com
· Following the combination, and subject to their election, the Board of Kuros Biosciences will consist of Christian Itin (Chairman), Dominik Ellenrieder (Vice Chairman), Didier Cowling, Harry Welten, Arnd Kaltofen, Jörg Neermann, Gerhard Ries and Vincent Ossipow.
The Biggest European Medtech Exit of Just Happenedwww.labiotech.eu › medical › symetis-boston-scienti...
www.labiotech.eu
· ... a new standard in the TAVI market with a broad and clinically differentiated offering,” commented Dominik Ellenrieder, Symetis' Chairman.
Medartis raises CHF142.6M in IPO | S&P Global Market Intelligencewww.spglobal.com › news-insights › trending
www.spglobal.com
· Vice Chairman Dominik Ellenrieder owns a 7.9% stake, while Medartis co-founder and CEO Willi Miesch owns 6%. The free float amounts to 24.6%, ...
sortiert nach Relevanz / Datum